Vimarsana
Biggest News Aggregation in the World

Genesis Medtech News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Genesis Medtech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Genesis Medtech Today - Breaking & Trending Today

Drug-Eluting Balloons Global Market is Expected to Expand at a Healthy Growth Rate of ~8% by 2028, Predicts DelveInsight - Vimarsana News

Drug-Eluting Balloons Global Market is Expected to Expand at a Healthy Growth Rate of ~8% by 2028, Predicts DelveInsight

/PRNewswire/ -- DelveInsight's Drug-Eluting Balloons Market Insights report provides the current and forecast market analysis, individual leading drug-eluting...

Shockwave Medical (SWAV) Q3 2023 Earnings Call Transcript - Vimarsana News

Shockwave Medical (SWAV) Q3 2023 Earnings Call Transcript

SWAV earnings call for the period ending September 30, 2023.

Source: fool.com
ShockWave Medical, Inc. (NASDAQ:SWAV) Q3 2023 Earnings Call Transcript - Vimarsana News

ShockWave Medical, Inc. (NASDAQ:SWAV) Q3 2023 Earnings Call Transcript

Operator: Good afternoon and welcome to Shockwave’s Third Quarter 2023 Earnings Conference Call. [Operator Instructions] As a reminder, this call is being recorded for replay purposes.

First of its kind 'J-Valve' surgery performed at Christ Hospital - Vimarsana News

First of its kind 'J-Valve' surgery performed at Christ Hospital

The successful procedure was done by Dr. Dean Kereiakes, Dr. Santiago Garcia and the team at The Lindner Research Center at The Christ Hospital Health Network earlier this month.

Source: wlwt.com
Genesis MedTech introduces China's first domestic brand of NPMA-approved antibacterial sutures - Vimarsana News

Genesis MedTech introduces China's first domestic brand of NPMA-approved antibacterial sutures

/PRNewswire/ -- Genesis MedTech, a leading medical device company, today announced that its absorbable sutures with antibacterial protection have successfully...